DocMorris Valuation
Is DOCM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DOCM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DOCM (CHF19.86) is trading below our estimate of fair value (CHF93.08)
Significantly Below Fair Value: DOCM is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DOCM?
Key metric: As DOCM is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is DOCM's PS Ratio? | |
---|---|
PS Ratio | 0.3x |
Sales | CHF 1.00b |
Market Cap | CHF 259.49m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.5x |
Enterprise Value/EBITDA | -7.9x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does DOCM's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | n/a |
Price-To-Sales vs Peers: DOCM is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.4x).
Price to Sales Ratio vs Industry
How does DOCM's PS Ratio compare vs other companies in the Consumer Retailing Industry?
0 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
0 Companies | Estimated Growth | Market Cap |
---|
Price-To-Sales vs Industry: DOCM is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Consumer Retailing industry average (0.4x).
Price to Sales Ratio vs Fair Ratio
What is DOCM's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.3x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate DOCM's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 19.86 | CHF 35.92 +80.8% | 37.3% | CHF 60.00 | CHF 20.00 | n/a | 12 |
Jan ’26 | CHF 19.98 | CHF 46.92 +134.8% | 31.9% | CHF 75.00 | CHF 25.00 | n/a | 12 |
Dec ’25 | CHF 30.00 | CHF 52.33 +74.4% | 33.6% | CHF 90.00 | CHF 25.00 | n/a | 12 |
Nov ’25 | CHF 34.58 | CHF 52.50 +51.8% | 33.3% | CHF 90.00 | CHF 25.00 | n/a | 12 |
Oct ’25 | CHF 36.70 | CHF 65.92 +79.6% | 40.0% | CHF 125.00 | CHF 27.00 | n/a | 12 |
Sep ’25 | CHF 38.70 | CHF 78.00 +101.6% | 35.5% | CHF 125.00 | CHF 27.00 | n/a | 12 |
Aug ’25 | CHF 44.54 | CHF 88.50 +98.7% | 28.2% | CHF 125.00 | CHF 29.00 | n/a | 12 |
Jul ’25 | CHF 52.70 | CHF 98.58 +87.1% | 26.3% | CHF 130.00 | CHF 29.00 | n/a | 12 |
Jun ’25 | CHF 67.25 | CHF 99.24 +47.6% | 25.5% | CHF 130.00 | CHF 31.90 | n/a | 12 |
May ’25 | CHF 82.05 | CHF 99.24 +21.0% | 25.5% | CHF 130.00 | CHF 31.90 | n/a | 12 |
Apr ’25 | CHF 90.55 | CHF 88.91 -1.8% | 26.5% | CHF 115.00 | CHF 29.00 | n/a | 11 |
Mar ’25 | CHF 78.20 | CHF 77.92 -0.4% | 28.8% | CHF 105.00 | CHF 29.00 | n/a | 12 |
Feb ’25 | CHF 78.95 | CHF 77.92 -1.3% | 28.8% | CHF 105.00 | CHF 29.00 | CHF 19.86 | 12 |
Jan ’25 | CHF 73.75 | CHF 69.00 -6.4% | 31.9% | CHF 102.00 | CHF 29.00 | CHF 19.98 | 12 |
Dec ’24 | CHF 59.50 | CHF 62.27 +4.7% | 31.4% | CHF 95.00 | CHF 29.00 | CHF 30.00 | 11 |
Nov ’24 | CHF 37.52 | CHF 62.27 +66.0% | 31.4% | CHF 95.00 | CHF 29.00 | CHF 34.58 | 11 |
Oct ’24 | CHF 50.80 | CHF 64.86 +27.7% | 30.1% | CHF 95.00 | CHF 29.50 | CHF 36.70 | 11 |
Sep ’24 | CHF 59.45 | CHF 62.38 +4.9% | 32.8% | CHF 95.00 | CHF 29.50 | CHF 38.70 | 12 |
Aug ’24 | CHF 53.30 | CHF 52.50 -1.5% | 27.0% | CHF 80.00 | CHF 27.00 | CHF 44.54 | 12 |
Jul ’24 | CHF 39.02 | CHF 51.25 +31.3% | 27.5% | CHF 80.00 | CHF 27.00 | CHF 52.70 | 12 |
Jun ’24 | CHF 30.58 | CHF 53.08 +73.6% | 23.4% | CHF 80.00 | CHF 37.00 | CHF 67.25 | 12 |
May ’24 | CHF 38.94 | CHF 53.62 +37.7% | 23.1% | CHF 80.00 | CHF 31.00 | CHF 82.05 | 13 |
Apr ’24 | CHF 42.18 | CHF 54.62 +29.5% | 22.7% | CHF 80.00 | CHF 31.00 | CHF 90.55 | 13 |
Mar ’24 | CHF 48.84 | CHF 54.33 +11.2% | 19.3% | CHF 71.00 | CHF 31.00 | CHF 78.20 | 12 |
Feb ’24 | CHF 33.40 | CHF 37.96 +13.6% | 61.4% | CHF 106.00 | CHF 19.00 | CHF 78.95 | 12 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/31 18:45 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DocMorris AG is covered by 21 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Volker Bosse | Baader Helvea Equity Research |
Gerhard Orgonas | Berenberg |
Ashley Wallace | BofA Global Research |